Prab at 12:07, 27 March 2024

2024-03-27T12:07:01Z

New page

'''Guanadrel''' is a [[postganglionic adrenergic blocking agent]] that is used in the management of [[hypertension]]. It works by inhibiting the release of [[norepinephrine]] from [[sympathetic nerves]], which leads to a decrease in [[blood pressure]]. Guanadrel is absorbed from the [[gastrointestinal tract]] and undergoes extensive [[first-pass metabolism]] in the [[liver]]. Its mechanism of action involves the depletion of norepinephrine from sympathetic nerve endings, which reduces the [[sympathetic nervous system]]'s activity on the [[heart]] and [[blood vessels]], leading to lower blood pressure.

==Mechanism of Action==
Guanadrel's primary mechanism involves blocking the release of norepinephrine, a key [[neurotransmitter]] in the sympathetic nervous system, from nerve endings. This action results in a decrease in [[vasoconstriction]] (narrowing of the blood vessels) and a reduction in [[heart rate]], both of which contribute to lowering blood pressure. Unlike some other antihypertensive agents, Guanadrel specifically targets the sympathetic nervous system without directly affecting the [[renal]] function or [[sodium]] and [[water]] retention.

==Pharmacokinetics==
After oral administration, Guanadrel is absorbed through the gastrointestinal tract. However, its bioavailability is significantly reduced due to first-pass metabolism in the liver. The drug's effects on blood pressure begin within a few hours after ingestion, with the peak effect occurring within several hours. The duration of its antihypertensive effect can last up to 24 hours. Guanadrel is metabolized in the liver and excreted primarily in the urine.

==Chemistry==
Guanadrel, (1,4-dioxaspiro[4,5]dec-2-ylmethyl)guanidine, is synthesized when [[cyclohexanone]] undergoes ketalization by 3-chloro-1,2-propanediol, forming 2-chloromethyl-1,4-dioxyspiro[4,5]decane, which is further reacted with sodium phthalimide. After alkaline hydrazinolysis, the resulting phthalimide derivative is transformed into 2-aminomethyl-1,4-dioxyspiro[4,5]decane, which is reacted with S-methylthiourea, giving the desired guanadrel.
[[File:Guanadrel synthesis.png|800px]]
==Clinical Use==
Guanadrel is used in the treatment of mild to moderate essential hypertension. It may be used alone or in combination with other antihypertensive agents to achieve better blood pressure control. Due to its mechanism of action, Guanadrel is particularly useful in patients who cannot tolerate other types of antihypertensive medications due to side effects or contraindications.

==Side Effects==
The use of Guanadrel can lead to several side effects, most of which are related to its sympatholytic activity. Common side effects include [[dizziness]], [[headache]], [[fatigue]], and [[orthostatic hypotension]] (a sudden drop in blood pressure when standing up). Less common but more serious side effects may include severe hypotension, particularly in patients with existing [[renal insufficiency]] or those taking other antihypertensive medications.

==Contraindications==
Guanadrel is contraindicated in patients with a history of [[hypersensitivity]] to the drug or its components. It should be used with caution in patients with severe coronary artery disease, cerebrovascular disease, or renal insufficiency, as these conditions may be exacerbated by the drug's effects on blood pressure.

==Conclusion==
Guanadrel is an effective antihypertensive agent that works by blocking the release of norepinephrine from sympathetic nerve endings, leading to reduced blood pressure. While it is beneficial for patients with mild to moderate hypertension, its use must be carefully considered in patients with certain underlying conditions due to the potential for serious side effects.

[[Category:Antihypertensive agents]]

{{Pharmacology-stub}}

Guanadrel - Revision history

Prab at 12:07, 27 March 2024